Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):587–590. doi: 10.1111/j.1476-5381.1992.tb09023.x

Mechanism of action of MY-1250, an active metabolite of Repirinast, in inhibiting histamine release from rat mast cells.

M Takei 1, K Endo 1, K Takahashi 1
PMCID: PMC1908474  PMID: 1378339

Abstract

1. When MY-1250 (3.6 x 10(-5) M) was added to mast cells, it caused a rapid increase in adenosine 3':5'-cyclic monophosphate (cyclic AMP) and decrease in adenosine 5'-triphosphate (ATP), both of which recovered to their original levels within 2 min. The accumulation of cyclic AMP was maximal at 20 s after challenge with MY-1250. The minimum level of ATP was observed at 20 s after addition of MY-1250. 2. The initial rise in [Ca2+]i and the histamine release induced by DNP-AS antigen (40 micrograms ml-1) was most strongly inhibited at 20 s after incubation of the mast cells with MY-1250. 3. MY-1250 strongly and dose-dependently inhibited the histamine release from rat mast cells induced by antigen. Moreover, MY-125 strongly inhibited calcium ion mobilization from the intracellular Ca(2+)-store. 4. These results suggested that the inhibitory mechanism of MY-1250 on the initial rise in [Ca2+]i and histamine release induced by antigen was due to the inhibition of ATP-dependent Ca(2+)-release from the intracellular Ca(2+)-stores.

Full text

PDF
587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hayashi H., Ichikawa A., Saito T., Tomita K. Inhibitory role of cyclic adenosine 3' 5'-monophosphate in histamine release from rat peritoneal mast cells in vitro. Biochem Pharmacol. 1976 Aug 15;25(16):1907–1913. doi: 10.1016/0006-2952(76)90198-2. [DOI] [PubMed] [Google Scholar]
  2. Ishizaka T. Biochemical analysis of triggering signals induced by bridging of IgE receptors. Fed Proc. 1982 Jan;41(1):17–21. [PubMed] [Google Scholar]
  3. Ishizaka T., Hirata F., Sterk A. R., Ishizaka K., Axelrod J. A. Bridging of IgE receptors activates phospholipid methylation and adenylate cyclase in mast cell plasma membranes. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6812–6816. doi: 10.1073/pnas.78.11.6812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lo T. N., Saul W., Beaven M. A. The actions of Ca2+ ionophores on rat basophilic (2H3) cells are dependent on cellular ATP and hydrolysis of inositol phospholipids. A comparison with antigen stimulation. J Biol Chem. 1987 Mar 25;262(9):4141–4145. [PubMed] [Google Scholar]
  5. Makino H., Saijo T., Ashida Y., Kuriki H., Maki Y. Mechanism of action of an antiallergic agent, amlexanox (AA-673), in inhibiting histamine release from mast cells. Acceleration of cAMP generation and inhibition of phosphodiesterase. Int Arch Allergy Appl Immunol. 1987;82(1):66–71. doi: 10.1159/000234292. [DOI] [PubMed] [Google Scholar]
  6. Németh A., Röhlich P. Rapid separation of rat peritoneal mast cells with Percoll. Eur J Cell Biol. 1980 Feb;20(3):272–275. [PubMed] [Google Scholar]
  7. SAEKI K. EFFECTS OF COMPOUND 48/80, CHYMOTRYPSIN AND ANTI-SERUM ON ISOLATED MAST CELLS UNDER AEROBIC AND ANAEROBIC CONDITIONS. Jpn J Pharmacol. 1964 Sep;14:375–390. doi: 10.1254/jjp.14.375. [DOI] [PubMed] [Google Scholar]
  8. SHORE P. A., BURKHALTER A., COHN V. H., Jr A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 1959 Nov;127:182–186. [PubMed] [Google Scholar]
  9. Stanley P. E., Williams S. G. Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme. Anal Biochem. 1969 Jun;29(3):381–392. doi: 10.1016/0003-2697(69)90323-6. [DOI] [PubMed] [Google Scholar]
  10. Sullivan T. J., Parker K. L., Eisen S. A., Parker C. W. Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentrations and histamine release. J Immunol. 1975 May;114(5):1480–1485. [PubMed] [Google Scholar]
  11. Tada T., Okumura K. Regulation of homocytotropic antibody formation in the rat. I. Feed-back regulation by passively administered antibody. J Immunol. 1971 Apr;106(4):1002–1011. [PubMed] [Google Scholar]
  12. Takahashi K. Effects of MY-5116 on experimental asthma in rats and guinea pigs. Arerugi. 1986 Oct;35(10):1037–1046. [PubMed] [Google Scholar]
  13. Takahashi K., Yamada N., Endoh K., Yasumura K. Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic agent, on the release of mediators from guinea pig lung fragments. Arerugi. 1986 Sep;35(9):982–987. [PubMed] [Google Scholar]
  14. Takei M., Endo K., Takahashi K. Inhibition of histamine release from rat peritoneal mast cells by MY-1250, an active metabolite of Repirinast (MY-5116). Int Arch Allergy Appl Immunol. 1990;93(2-3):237–241. doi: 10.1159/000235307. [DOI] [PubMed] [Google Scholar]
  15. Takei M., Urashima H., Endo K., Muramatu M. Role of calcium in histamine release from rat mast cells activated by various secretagogues; intracellular calcium mobilization correlates with histamine release. Biol Chem Hoppe Seyler. 1989 Jan;370(1):1–10. doi: 10.1515/bchm3.1989.370.1.1. [DOI] [PubMed] [Google Scholar]
  16. Tsien R. Y., Pozzan T., Rink T. J. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J Cell Biol. 1982 Aug;94(2):325–334. doi: 10.1083/jcb.94.2.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yamada N., Takahashi K., Endoh K., Arai Y. [Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents]. Nihon Yakurigaku Zasshi. 1986 Sep;88(3):229–237. doi: 10.1254/fpj.88.229. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES